CytoMed Therapeutics Statistics

Total Valuation

GDTC has a market cap or net worth of $25.51 million. The enterprise value is $20.79 million.

Market Cap	25.51M
Enterprise Value	20.79M

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

GDTC has 11.54 million shares outstanding. The number of shares has increased by 29.10% in one year.

Current Share Class	11.54M
Shares Outstanding	11.54M
Shares Change (YoY)	+29.10%
Shares Change (QoQ)	-0.01%
Owned by Insiders (%)	18.79%
Owned by Institutions (%)	0.05%
Float	3.55M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	77.23
Forward PS	48.09
PB Ratio	3.40
P/TBV Ratio	3.41
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	62.94
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 21.53, with a Debt / Equity ratio of 0.04.

Current Ratio	21.53
Quick Ratio	19.20
Debt / Equity	0.04
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-170.36

Financial Efficiency

Return on equity (ROE) is -26.26% and return on invested capital (ROIC) is -17.87%.

Return on Equity (ROE)	-26.26%
Return on Assets (ROA)	-17.44%
Return on Capital (ROIC)	-17.87%
Revenue Per Employee	$11,795
Profits Per Employee	-$80,701
Employee Count	28
Asset Turnover	0.04
Inventory Turnover	n/a

Taxes

In the past 12 months, GDTC has paid $482 in taxes.

Income Tax	482
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -40.59% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-40.59%
50-Day Moving Average	2.06
200-Day Moving Average	2.03
Relative Strength Index (RSI)	49.52
Average Volume (20 Days)	13,285

Short Selling Information

The latest short interest is 95,341, so 0.83% of the outstanding shares have been sold short.

Short Interest	95,341
Short Previous Month	116,076
Short % of Shares Out	0.83%
Short % of Float	2.69%
Short Ratio (days to cover)	4.21

Income Statement

In the last 12 months, GDTC had revenue of $330,254 and -$2.26 million in losses. Loss per share was -$0.20.

Revenue	330,254
Gross Profit	330,372
Operating Income	-2.55M
Pretax Income	-3.12M
Net Income	-2.26M
EBITDA	-2.30M
EBIT	-2.55M
Loss Per Share	-$0.20

Full Income Statement

Balance Sheet

The company has $5.03 million in cash and $315,935 in debt, giving a net cash position of $4.72 million or $0.41 per share.

Cash & Cash Equivalents	5.03M
Total Debt	315,935
Net Cash	4.72M
Net Cash Per Share	$0.41
Equity (Book Value)	7.50M
Book Value Per Share	0.65
Working Capital	5.42M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$1.88 million and capital expenditures -$701,736, giving a free cash flow of -$2.61 million.

Operating Cash Flow	-1.88M
Capital Expenditures	-701,736
Free Cash Flow	-2.61M
FCF Per Share	-$0.23

Full Cash Flow Statement

Margins

Gross Margin	100.04%
Operating Margin	-773.56%
Pretax Margin	-684.13%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

GDTC does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-29.10%
Shareholder Yield	-29.10%
Earnings Yield	-8.86%
FCF Yield	-10.24%

Analyst Forecast

The average price target for GDTC is $5.00, which is 126.22% higher than the current price. The consensus rating is "Buy".

Price Target	$5.00
Price Target Difference	126.22%
Analyst Consensus	Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

GDTC has an Altman Z-Score of 37.35 and a Piotroski F-Score of 2.

Altman Z-Score	37.35
Piotroski F-Score	2